Back to MW MARSHALL WACE, LLP

EDITEDIT
Showing 7 of 19 quarters

Position history for MWMARSHALL WACE, LLP's holdings in EDITAS MEDICINE INC

MARSHALL WACE, LLP holds 2M shares of EDIT (EDITAS MEDICINE INC), worth $6.6M as of 2026-Q2. The position was increased (+868.7% shares). EDIT represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$6.6M

Current Shares

2M

Total Value Change

+$6.4M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+868.7%
$6.6M0.0%$3.24
44
2026-Q1
New
210,308
-
$519,4610.0%$2.04
33
2025-Q3
Exited
0
-100.0%
$00.0%$3.52
0
2025-Q2
Decreased
142,008
-41.4%
$312,4180.0%$2.28
0
2025-Q1
New
242,376
-
$281,1550.0%$1.25
32
2024-Q4
Exited
0
-100.0%
$00.0%$1.20
0
2024-Q3
Decreased
63,759
-85.8%
$217,4190.0%$3.48
0

Other major holders of EDIT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, Sumitomo Mitsui Trust Group, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used